The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Macrogol for the treatment of constipation in Parkinson’s disease. A randomized placebo-controlled study
Abstract
Chronic constipation is the most frequent symptom of autonomic system involvement in Parkinson's disease (PD). Quite often the symptom is severe and impairs patients' quality of life. The objective of this study is to determine the efficacy and safety of an isosmotic macrogol solution for the treatment of constipation in PD patients, in a double-blind, placebo-controlled study. A total of 57 PD patients with constipation were randomly assigned to receive an isosmotic macrogol electrolyte solution (MC-ES; 29 patients) or placebo (28 patients) for 8 weeks. Treatment efficacy was defined as complete relief of the symptom or a marked improvement of two of the following indicators: stool frequency, straining, stool consistency, use of rectal laxatives as a rescue therapy. The responder rates were significantly higher in the MC-ES group both at the first (4 weeks; P < 0.0003) and at the final evaluation (8 weeks; P < 0.0012). The frequency of bowel movements (P < 0.002) and stool consistency (P < 0.006) were significantly changed in the MC-ES group compared to the placebo group. At the final evaluation, a rectal laxative was used by 2 (12.5%) patients on placebo, whereas no use was recorded in the MC-ES group. Responder rate for straining showed a favorable trend in patients treated with macrogol versus placebo. Unified Parkinson's Disease Rating Scale Part III and Parkinson's Disease Questionnaire (PDQ-39) did not show any significant modification in either group during the 8-week…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Randomized controlled trials have demonstrated benefit of polyethylene glycol 3350 (Zangaglia et al., 2007) and lubiprostone (Ondo et al., 2012) in PD-related constipation, and dopaminergic agents such as apomorphine can influence defecatory function (Edwards et al., 1993b).”
From Autonomic nervous system and gastrointestinal manifestations with an emphasis on gastric dysfunction (2026) · cites this paper as Zangaglia et al., 2007
Citations
Cites
Statistical Methods in Medical Research.
Armitage, P. (1972) · Biometrics · doi:10.2307/2556182 · Cited by 5,383
Functional bowel disorders and functional abdominal pain
Thompson, W. G., Longstreth, G. F., Drossman, D. A., Heaton, K. W., Irvine, E. J., & Müller-Lissner, S. A. (1999) · Gut · doi:10.1136/gut.45.2008.ii43 · Cited by 2,440
Members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale
Fahn, S. (1987) · Medical Entomology and Zoology · Cited by 2,163
Gastrointestinal dysfunction in Parkinson's disease
Pfeiffer, R. F. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00307-7 · Cited by 933
Frequency of Bowel Movements and the Future Risk of Parkinson’s Disease
Abbott, R. D., Petrovitch, H., White, L. R., Masaki, K. H., Tanner, C. M., Curb, J. D., Grandinetti, A., Blanchette, P. L., Popper, J. S., & Ross, G. W. (2001) · Neurology · doi:10.1212/wnl.57.3.456 · Cited by 839
Irreversible motor impairment in young addicts ? ephedrone, manganism or both?
Sikk, K., Taba, P., Haldre, S., Bergquist, J., Nyholm, D., Zjablov, G., Asser, T., & Aquilonius, S. (2007) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2007.00818.x · Cited by 664
Peto, V., Jenkinson, C., & Fitzpatrick, R. M. (1998) · Journal of Neurology · doi:10.1007/pl00007730 · Cited by 590
Glial pathology but absence of apoptotic nigral neurons in long‐standing Parkinson's disease
Banati, R. B., Daniel, S. E., & Blunt, S. B. (1998) · Movement Disorders · doi:10.1002/mds.870130205 · Cited by 430
Gastrointestinal symptoms in Parkinson's disease
Edwards, L. L., Pfeiffer, R. F., Quigley, E. M. M., Hofman, R., & Balluff, M. (1991) · Movement Disorders · doi:10.1002/mds.870060211 · Cited by 373
Singaram, C., Gaumnitz, E., Torbey, C., Ashraf, W., Quigley, E. M., Sengupta, A., & Pfeiffer, R. F. (1995) · The Lancet · doi:10.1016/s0140-6736(95)92707-7 · Cited by 364
Flagged first, then by citations
Research works printed but not linked: 2
- Parkinson J, 1817, An essay on the shaking palsy
- Wiesel PH, 2001, Management of faecal incontinence and constipation in adults with central neurological disease, Cochrane Database Syst Rev, 2
Cited by
Sorted by citations
Items 101–176 of 176
An overview on disease modifying and symptomatic drug treatments for multiple sclerosis
Costa, G. D., Leocani, L., Rodegher, M., Chiveri, L. R., Gradassi, A., & Comi, G. (2024) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2024.2410393 · Cited by 15
Non-motor Symptoms in Parkinson’s Disease
Uc, E. Y., Tippin, J., Chou, K. L., Erickson, B. A., Doerschug, K. C., & Fletcher, D. M. J. (2012) · European Neurological Review · doi:10.17925/enr.2012.07.01.35 · Cited by 10
An update on the recognition and treatment of autonomic symptoms in Parkinson’s disease
Jost, W. H. (2017) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2017.1345307 · Cited by 10
Managing autonomic dysfunction in Parkinson’s disease: a review of emerging drugs
Kulshreshtha, D., Ganguly, J., & Jog, M. (2020) · Expert Opinion on Emerging Drugs · doi:10.1080/14728214.2020.1729120 · Cited by 11
Gastrointestinale Störungen beim idiopathischen Parkinson-Syndrom
Tredici, K. D., & Jost, W. H. (2012) · Der Nervenarzt · doi:10.1007/s00115-012-3575-9 · Cited by 11
Treatment strategies for nonmotor manifestations of Parkinson's disease
Reichmann, H., & Ziemssen, T. (2009) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560902811605 · Cited by 10
Efficacy and Safety of Elobixibat in Parkinson's Disease with Chronic Constipation: CONST‐PD Study
Hatano, T., Oyama, G., Shimo, Y., Ogaki, K., Nishikawa, N., Nakamura, R., Tsunemi, T., Ogawa, T., Eguchi, H., Daida, K., et al. (2024) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.13972 · Cited by 11
Nichtmotorische Symptome beim Morbus Parkinson
Jost, W. H. (2017) · Der Nervenarzt · doi:10.1007/s00115-017-0346-7 · Cited by 9
Nonmotor Disorders and Their Correlation With Dopamine
Martínez‐Castrillo, J. C., Vela, L., del Val, J., & Cánovas, A. A. (2011) · The Neurologist · doi:10.1097/nrl.0b013e318239669f · Cited by 8
Gastrointestinal Care of the Parkinson Patient
Legge, J., Fleming, N., & Cloud, L. J. (2019) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2019.09.003 · Cited by 8
Maeda, K., Katsuno, H., Tsunoda, A., Seki, M., Takao, Y., Mimura, T., Yamana, T., & Yoshioka, K. (2021) · Journal of the Anus Rectum and Colon · doi:10.23922/jarc.2020-075 · Cited by 8
Todd, C. L., Johnson, E. E., Stewart, F. J., Wallace, S. A., Bryant, A., Woodward, S., & Norton, C. S. (2024) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002115.pub6 · Cited by 11
Gastrointestinal Dysfunction in Multiple Sclerosis and Related Conditions
Sakakibara, R. (2023) · Seminars in Neurology · doi:10.1055/s-0043-1771462 · Cited by 7
Systemic disorders that affect gastrointestinal motility
Lee, Y. Y., Haque, M. M., Lawenko, R. M., & Sharma, A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813037-7.00043-1 · Cited by 7
Evaluation and Treatment of Neurogenic Bowel Dysfunction – A Review
Kumar, L., Athanasakos, E., & Emmanuel, A. V. (2016) · European Neurological Review · doi:10.17925/enr.2016.11.02.109 · Cited by 7
Pervin, F., Edwards, C. Y., & Lippa, C. F. (2015) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317515581704 · Cited by 6
Parkinson's disease: treatment and non-motor features
Macphee, G. J. A., & Stewart, D. A. (2012) · Reviews in Clinical Gerontology · doi:10.1017/s0959259812000093 · Cited by 6
Hatano, T., Oyama, G., Shimo, Y., Ogaki, K., Nishikawa, N., Fukae, J., Nakamura, R., Kurita, N., Tsunemi, T., Oji, Y., et al. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-054129 · Cited by 5
Mohammed, C., Fuego, J. P., Garcia, K. V., Jamil, H., Rajesh, R. Y., Escobar, A. S., Hassan, M. J., & Rai, M. (2024) · Cureus · doi:10.7759/cureus.57055 · Cited by 5
Klingelhoefer, L., & Reichmann, H. (2015) · Journal of Parkinson s Disease · doi:10.3233/jpd-150574 · Cited by 5
Manejo de la disfunción autonómica en la enfermedad de Parkinson
Crespo-Burillo, J. A., & Alejos, R. A. (2015) · Revista de Neurología · doi:10.33588/rn.6008.2014341 · Cited by 4
STW5 (Iberogast®) for constipation in Parkinson's disease
Roy, M., Péré, M., Damier, P., Varannes, S. B. D., Derkinderen, P., & Rouaud, T. (2020) · Revue Neurologique · doi:10.1016/j.neurol.2020.06.005 · Cited by 4
Autonomic dysfunction and management
Richard B. Dewey Jr., P. K. (2013) · CRC Press eBooks · doi:10.1201/b14361-9 · Cited by 4
Dopamine Replacement Therapy in Parkinson’s Disease: Past, Present and Future
Cenci, M. A., & Odin, P. (2008) · Humana Press eBooks · doi:10.1007/978-1-60327-252-0_20 · Cited by 4
Management of Gastrointestinal Symptoms in Parkinson’s Disease
Chiang, H., & Lin, C. (2025) · Journal of Central Nervous System Disease · doi:10.1177/11795735251370014 · Cited by 3
Preechakawin, N., Maneerattanaporn, M., Geeratragool, T., Srivanitchapoom, P., Pitakpatapee, Y., & Leelakusolvong, S. (2025) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000003771 · Cited by 3
Panza, F., Lozupone, M., Watling, M., & Imbimbo, B. P. (2020) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2020.1828350 · Cited by 3
Gastroparesia y otros síntomas gastrointestinales en la enfermedad de Parkinson
Santos‐García, D., Fonticoba, T. D. D., Pérez, C. T., Ruiz, I. E., Castro, E. S., Briones, P. C., & Arribi, M. M. (2015) · Revista de Neurología · doi:10.33588/rn.6106.2015203 · Cited by 3
Wang, S., Zhou, F., Fang, X., Zhang, H., Yang, W., Xia, L., Chen, Y., Tan, J., & Wu, Y. X. (2025) · Geriatric Nursing · doi:10.1016/j.gerinurse.2025.103600 · Cited by 2
Genetic predispositions and nutritional strategies: a review of nutrigenomics in Parkinson’s disease
Mohamed, Y. A., Nadeem, A. A. A., Ismail, L. M., Ghallab, Y. K., Ouédraogo, R. J., Elhelw, J., Ahmed, M., & Tharwat, E. K. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.12.012 · Cited by 2
An overview of the current management and emerging therapies of Multiple system atrophy
Sorrentino, C., Baldelli, L., Buonaura, G. C., & Pellecchia, M. T. (2026) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2025.2605711 · Cited by 2
Intestinal Dysfunction in Parkinson’s Disease
Pfeiffer, R. F. (2012) · Humana Press eBooks · doi:10.1007/978-1-60761-429-6_10 · Cited by 2
Gastrointestinal Dysfunctions in Parkinson’s Disease
Kim, J., & Sung, H. Y. (2015) · Journal of the Korean Neurological Association · doi:10.17340/jkna.2015.4.1 · Cited by 2
Parkinson Disease-Mediated Gastrointestinal Disorders and Rational for Combinatorial Therapies
Ali, A., Yin, N. B., Rehman, A., & Justilien, V. (2016) · Medical Sciences · doi:10.3390/medsci4010001 · Cited by 2
Evaluating the Scope of Gastrointestinal Symptoms of Parkinson's Disease: A Review of the Evidence
Essa, H., & Hamdy, S. (2016) · Neuroenterology · doi:10.4303/ne/235955 · Cited by 2
Management of Nonmotor Symptoms of Parkinson's Disease
Gálvez-Jiménez, N., Fernandez, H. H., Espay, A. J., & Fox, S. H. (2016) · Cambridge University Press eBooks · doi:10.1017/cbo9781107284210.010 · Cited by 2
Impact of Neurogenic Lower Urinary Tract Dysfunction on Bowel Symptoms
Burton, C., Khorsandi, S., & Comiter, C. V. (2023) · Current Bladder Dysfunction Reports · doi:10.1007/s11884-023-00702-w · Cited by 1
Ernährung bei der Parkinson-Krankheit
Ceballos-Baumann, A., & Fietzek, U. M. (2025) · Nervenheilkunde · doi:10.1055/a-2512-0254 · Cited by 1
Update on the Treatment of Autonomic Disorders
Eid, A. M., Vázquez-Vélez, G. E., Maliszewski, B., Butler, M., Bucelli, R. C., Perlmutter, J. S., & Luca, D. G. D. (2025) · Current Treatment Options in Neurology · doi:10.1007/s11940-025-00830-0 · Cited by 1
Abbas, A., Sabet, H., Hawas, Y., Yousef, O., Kassar, O., AbdelMeseh, M., Khatatbeh, A. E., Lashin, B. I., Awad, H., Cloud, L. J., et al. (2025) · Neuromodulation Technology at the Neural Interface · doi:10.1016/j.neurom.2025.07.005 · Cited by 1
Constipation Treatment in Neurological Disorders
Luca, G., Domenico, P., Caterina, P., & Giovambattista, D. (2012) · InTech eBooks · doi:10.5772/29813 · Cited by 5
Gastrointestinal complications of movement disorders
Lehosit, J. B., & Cloud, L. J. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9781139175845.026 · Cited by 1
Johnson, M., & Johnson, J. L. (2016) · Adelaide Research & Scholarship (AR&S) (University of Adelaide) · Cited by 1
Walia, V., & Garg, M. (2018) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/978-1-5225-5282-6.ch014 · Cited by 1
Rating scales for dysautonomia in Parkinson's disease
Diaconu, Ș., Irincu, L., Ivan, I., & Falup‐Pecurariu, C. (2021) · International review of movement disorders · doi:10.1016/bs.irmvd.2021.08.008 · Cited by 1
Management of Neurogenic Bowel Dysfunction
Emmanuel, A. V. (2018) · Cambridge University Press eBooks · doi:10.1017/9781316882290.019 · Cited by 1
Gastrointestinal and Swallowing Disturbances in Parkinson's Disease
Pfeiffer, R. F. (2011) · Parkinson s Disease · doi:10.1002/9781444397970.ch24 · Cited by 1
Keeping things Moving: Preventing and Managing Constipation
Gandell, D., & Alibhai, S. M. H. (2010) · Wiley eBooks · doi:10.1002/9781118281796.ch11 · Cited by 1
Autonomic nervous system and gastrointestinal manifestations with an emphasis on gastric dysfunction
Shouman, K., Camilleri, M., & Singer, W. (2026) · Autonomic Neuroscience · doi:10.1016/j.autneu.2026.103474
Medikamentöse Therapie des fortgeschrittenen Morbus Parkinson
Katzenschlager, R. (2014) · Journal für Kardiologie (Krause & Pachernegg GmbH)
Stacy, M. A., & Jankovic, J. J. (2011) · Parkinson s Disease · doi:10.1002/9781444397970.ch35
Nicht motorische Symptome bei Morbus Parkinson
Wenzel, K. (2014) · psychopraxis neuropraxis · doi:10.1007/s00739-014-0192-3
Constipation in the Elderly: Investigation and Management
Krogh, K., & Laurberg, S. (2009) · Aging Health · doi:10.2217/ahe.09.64
Tratamento da obstipação intestinal em pacientes com doença de Parkinson: uma revisão sistemática
de Oliveira, M. L. C., Viana, L. G., Amancio, T. G., Liz, M., & de Oliveira, C. (2013)
Lessons and challenges of trials for other nonmotor complications of Parkinson's disease
Micheli, F. E., & Zúñiga‐Ramírez, C. (2016) · Cambridge University Press eBooks · doi:10.1017/cbo9781107284210.031
Non-motor Symptom Management in Parkinson’s Disease
TOLOSA, E. S., Gaig, C., & Acevedo, L. (2013) · Oxford University Press eBooks · doi:10.1093/med/9780199609536.003.0011
Clinical Trials in Parkinson's Diease: Lessons, Controversies and Challenges
(2016) · Cambridge University Press eBooks · doi:10.1017/cbo9781107284210.022
Medical Treatment of Parkinson’s Disease
Valadas, A., & Ferreira, J. J. (2017) · Springer eBooks · doi:10.1007/978-3-7091-1628-9_14
van der Steeg, H., Bremers, A. J. A., & de Blaauw, I. (2018) · Springer eBooks · doi:10.1007/978-3-319-90997-4_18
Treatment of Constipation in Parkinson’s Disease
Cloud, L. J. (2019) · Current clinical neurology · doi:10.1007/978-3-319-97897-0_13
Clinical Trials for Constipation in Parkinson’s Disease
Vernetti, P. M. (2020) · Neuromethods · doi:10.1007/978-1-0716-0912-5_15
Walia, V., & Garg, M. (2020) · IGI Global eBooks · doi:10.4018/978-1-7998-3441-0.ch002
Autonomic dysfunction and management
Dewey, R. B., Khemani, P., Karunapuzha, C. A., & Chitnis, S. (2013) · Informa Healthcare eBooks · doi:10.3109/9781841849096.006
Antonini, A. (2011) · doi:10.1007/978-1-908517-60-9_10
Symptomatische Therapie der Multiplen Sklerose
Becker, J., Hoppe, K., Müllers, M., Pompsch, M., Rogozinski, R., Strunk, D., & Kramer, M. G. (2023) · DGNeurologie · doi:10.1007/s42451-023-00543-1
Mehta, S., Sahni, N., Takkar, A., Mahesh, K. V., Shree, R., Bhati, K., & Kalia, K. (2024) · Journal of Postgraduate Medicine Education and Research · doi:10.5005/jp-journals-10028-1661
Chaudhuri, К. R., Jenner, P. G., Leta, V., Jones, S., & Boura, I. (2025) · Cambridge University Press eBooks · doi:10.1017/9781009222648.026
Parkinson-Krankheit – nicht-motorische Symptome für die Praxis
Jost, W. H. (2025) · Neurologie up2date · doi:10.1055/a-2565-7885
Hegelmaier, T., Duscha, A., Desel, C., Würtele, L.-M., Peplinski, J., Jauk, D., Troisi, R., Klietz, M., Faissner, S., Müller, T., et al. (2026) · Neurology and Therapy · doi:10.1007/s40120-026-00972-6
The mechanisms and management of fecal incontinence in geriatric neurological diseases
Sakakibara, R. (2026) · Clinical Autonomic Research · doi:10.1007/s10286-026-01232-1
Pallauf, C., Weck, C. E., Brandl, C., & Lorenzl, S. (2026) · Journal of Neural Transmission · doi:10.1007/s00702-026-03255-4
Gastrointestinal manifestations of Parkinson's disease
Pfeiffer, R. F., & Quigley, E. M. M. (2026) · Autonomic Neuroscience · doi:10.1016/j.autneu.2026.103475
Parkinson-Krankheit – nicht-motorische Symptome für die Praxis (Teil 2)
Jost, W. H. (2026) · Nervenheilkunde · doi:10.1055/a-2885-7251
Metadata
- Authors
- Zangaglia, R., Martignoni, E., Glorioso, M., Ossola, M., Riboldazzi, G., Calandrella, D., Brunetti, G., & Pacchetti, C.
- Affiliations
- Fondazione Istituto Neurologico Nazionale Casimiro Mondino (IT)
- Università degli Studi del Piemonte Orientale “Amedeo Avogadro” (IT)
- University of Insubria (IT)
- Corresponding author
- Zangaglia, Roberta
- Venue
- Movement Disorders
- Publisher
- Wiley
- Published
- 2007-06-12
- Volume
- 22
- Issue
- 9
- Pages
- 1239-1244
- ISSN
- 0885-3185 (ISSN-L)
- 1531-8257
- OpenAlex
- W1966941681
- Cited by
- 177
- References
- 34
- Citations by year
- 2026: 7 · 2025: 12 · 2024: 6 · 2023: 8 · 2022: 7 · 2021: 9 · 2020: 9 · 2019: 8 · 2018: 10 · 2017: 6 · 2016: 14 · 2015: 14 · 2014: 5 · 2013: 15 · 2012: 10
- FWCI
- 7.18
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Movement Disorders (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Health Sciences › Medicine › Urology › Pelvic floor disorders treatments
- Keywords
- Parkinson's disease, constipation, macrogol, polyethylene glycol electrolyte solution, autonomic dysfunction, stool frequency, stool consistency, straining, treatment efficacy and safety
- MeSH terms
- Aged, Constipation, Double-Blind Method, Female, Humans, Male, Parkinson Disease, Polyethylene Glycols, Severity of Illness Index, Surface-Active Agents, Time Factors, Chi-Square Distribution
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review